IgA antibody immunotherapy targeting GD2 is effective in preclinical neuroblastoma models

Stip MC, Evers M, Nederend M, Chan C, Reiding KR, Damen MJ, Heck AJR, Koustoulidou S, Ramakers R, Krijger GC, Roos Rd, Souteyrand E, Cornel AM, Dierselhuis MP, Jansen M, Boer Md, Valerius T, Tetering G, Leusen JHW, Meyer-Wentrup F.